• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有增强的物理化学性质和吸收的加巴喷丁-糖精共晶,制成口腔分散片。

Gabapentin-saccharin co-crystals with enhanced physicochemical properties and absorption formulated as oro-dispersible tablets.

机构信息

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Modern University for Technology and Information (MTI), Giza, Egypt.

出版信息

Pharm Dev Technol. 2020 Feb;25(2):227-236. doi: 10.1080/10837450.2019.1687521. Epub 2019 Nov 21.

DOI:10.1080/10837450.2019.1687521
PMID:31671004
Abstract

The physicochemical properties and absorption of a drug can be altered through cocrystallization with a suitable coformer. The aim of this study was to prepare and characterize Gabapentin (Gaba)-saccharine (sacch) sweet cocrystals for improvement of Gaba physicochemical properties, stability and absorption in addition to masking its taste. The prepared cocrystals were incorporated into oro-dispersible tablets as an attractive dosage form for pediatrics and adults. Gaba-sacch sweet cocrystals were prepared and characterized using FTIR, DSC, XRD and SEM analysis. They enhanced Gaba solubility and particle size distribution. Oro-dispersible tablets of the sweet cocrystals were prepared and evaluated in comparison to tablets prepared by Gaba-sacch physical mixture (PM). The tablets prepared by the cocrystals had lower wetting and disintegration time with enhanced drug release than those prepared with the physical mixture. The optimized formulation was evaluated for Gaba pharmacokinetics in rabbits in comparison to Gaba-sacch PM tablet and Gaba commercial oral capsules. This formulation had enhanced drug absorption through significant higher and AUC with shorter . The prepared Gaba-sacch sweet cocrystals oro-dispersible tablets, in addition to its enhanced and performance, can also enhance patient compliance through its palatable taste and ease of administration.

摘要

药物的物理化学性质和吸收可以通过与合适的共晶形成剂共结晶来改变。本研究旨在制备和表征加巴喷丁(Gaba)-糖精(sacch)甜味共晶,以改善 Gaba 的物理化学性质、稳定性和吸收,并掩盖其味道。所制备的共晶被掺入口腔分散片,作为儿科和成人的有吸引力的剂型。使用 FTIR、DSC、XRD 和 SEM 分析对 Gaba-sacch 甜味共晶进行了制备和表征。它们提高了 Gaba 的溶解度和粒度分布。与 Gaba-sacch 物理混合物 (PM) 制备的片剂相比,制备了甜味共晶的口腔分散片并进行了评估。与用物理混合物制备的片剂相比,共晶制备的片剂具有更低的润湿和崩解时间以及增强的药物释放。与 Gaba-sacch PM 片剂和 Gaba 商业口服胶囊相比,对该优化配方在兔体内的加巴喷丁药代动力学进行了评估。该配方通过显著提高和 AUC 以及缩短 来增强药物吸收。除了增强的 和 性能外,制备的 Gaba-sacch 甜味共晶口腔分散片还可以通过其可口的味道和易于给药来提高患者的依从性。

相似文献

1
Gabapentin-saccharin co-crystals with enhanced physicochemical properties and absorption formulated as oro-dispersible tablets.具有增强的物理化学性质和吸收的加巴喷丁-糖精共晶,制成口腔分散片。
Pharm Dev Technol. 2020 Feb;25(2):227-236. doi: 10.1080/10837450.2019.1687521. Epub 2019 Nov 21.
2
Formulation and biopharmaceutical evaluation of bitter taste masking microparticles containing azithromycin loaded in dispersible tablets.载于分散片的阿奇霉素微丸的包衣和生物药剂学评价。
Eur J Pharm Biopharm. 2018 May;126:187-200. doi: 10.1016/j.ejpb.2017.03.017. Epub 2017 Mar 27.
3
In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.以丙烯酸树脂E PO为口腔崩解片药物颗粒包衣剂的掩味效果的体外和体内研究。
Drug Dev Ind Pharm. 2017 May;43(5):723-731. doi: 10.1080/03639045.2016.1220572. Epub 2016 Aug 21.
4
Co-processed chitin-mannitol as a new excipient for Oro-dispersible tablets.共处理的几丁质-甘露醇作为口腔崩解片的新型辅料。
Mar Drugs. 2015 Mar 30;13(4):1739-64. doi: 10.3390/md13041739.
5
Evaluating Suspension Formulations of Theophylline Cocrystals With Artificial Sweeteners.评价含有人工甜味剂的茶碱共晶混悬剂配方。
J Pharm Sci. 2018 Feb;107(2):604-611. doi: 10.1016/j.xphs.2017.09.013. Epub 2017 Oct 5.
6
Comparative study of different approaches for preparation of chlorzoxazone orodispersible tablets.氯唑沙宗口腔崩解片不同制备方法的比较研究
Drug Dev Ind Pharm. 2017 May;43(5):742-750. doi: 10.1080/03639045.2016.1225753. Epub 2016 Sep 2.
7
Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.用于儿科和老年患者的口服柔性片剂(OFT)制剂的开发:一种新型的适合年龄的制剂平台。
AAPS PharmSciTech. 2017 Aug;18(6):1972-1986. doi: 10.1208/s12249-016-0666-0. Epub 2016 Dec 5.
8
Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.药物共晶的药物特性描述和评估:体外溶解条件和共晶形成剂类型的重要性。
Int J Pharm. 2013 Sep 10;453(2):380-8. doi: 10.1016/j.ijpharm.2013.05.048. Epub 2013 May 29.
9
Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.盐酸甲氧氯普胺口崩缓释片的研制及性能评价。
Arch Pharm Res. 2011 Oct;34(10):1691-700. doi: 10.1007/s12272-011-1013-3. Epub 2011 Nov 12.
10
Evaluation of performance of co crystals of mefloquine hydrochloride in tablet dosage form.盐酸甲氟喹共晶片剂制剂性能评估。
Drug Dev Ind Pharm. 2013 May;39(5):716-23. doi: 10.3109/03639045.2012.689764. Epub 2012 May 29.

引用本文的文献

1
Palatable Orally Disintegrating Tablets of Losartan Potassium Developed by Spray-drying Technique and Direct Compression Intended for Pediatric Use.采用喷雾干燥技术和直接压片法研制的用于儿科的氯沙坦钾口腔崩解片,口感良好。
AAPS PharmSciTech. 2025 Aug 13;26(7):212. doi: 10.1208/s12249-025-03208-2.
2
Co-crystallization in Antiepileptic Drugs: A Path Toward Better Therapeutic Outcomes.抗癫痫药物中的共结晶:通向更好治疗效果的途径。
Cureus. 2025 Apr 14;17(4):e82230. doi: 10.7759/cureus.82230. eCollection 2025 Apr.
3
A review on advancement of cocrystallization approach and a brief on screening, formulation and characterization of the same.
共结晶方法的进展综述及其筛选、制剂和表征简述。
Heliyon. 2024 Apr 1;10(7):e29057. doi: 10.1016/j.heliyon.2024.e29057. eCollection 2024 Apr 15.
4
Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation-Where Are We Now?热熔挤出:从理论到药物制剂的应用——我们现在在哪里?
AAPS PharmSciTech. 2024 Feb 14;25(2):37. doi: 10.1208/s12249-024-02749-2.
5
Polymorphism and Multi-Component Crystal Formation of GABA and Gabapentin.γ-氨基丁酸(GABA)和加巴喷丁的多态性及多组分晶体形成
Pharmaceutics. 2023 Sep 10;15(9):2299. doi: 10.3390/pharmaceutics15092299.
6
An Intragastric Delivery Device Employing FDM Technology: 3D-Printed Tablet Containing Green Developed Mosapride-Saccharin Co-crystals.采用 FDM 技术的胃内给药装置:含有绿色开发的莫沙必利-糖精共晶的 3D 打印片剂。
AAPS PharmSciTech. 2023 Jun 1;24(5):127. doi: 10.1208/s12249-023-02578-9.
7
Recent Advances on the Biological Study of Pharmaceutical Cocrystals.药物共晶的生物学研究进展。
AAPS PharmSciTech. 2022 Nov 17;23(8):303. doi: 10.1208/s12249-022-02451-1.
8
Besifloxacin-loaded ocular nanoemulsions: design, formulation and efficacy evaluation.载比沙氟沙星的眼部纳米乳:设计、配方和疗效评价。
Drug Deliv Transl Res. 2022 Jan;12(1):229-239. doi: 10.1007/s13346-021-00902-z. Epub 2021 Feb 11.
9
Structural Characterization of Co-Crystals of Chlordiazepoxide with -Aminobenzoic Acid and Lorazepam with Nicotinamide by DSC, X-Ray Diffraction, FTIR and Raman Spectroscopy.通过差示扫描量热法、X射线衍射、傅里叶变换红外光谱和拉曼光谱对氯氮卓与对氨基苯甲酸共晶体以及劳拉西泮与烟酰胺共晶体进行结构表征。
Pharmaceutics. 2020 Jul 9;12(7):648. doi: 10.3390/pharmaceutics12070648.